The world of sleep science is a fascinating one, and a recent study has shed light on an intriguing potential solution to sleep difficulties: hydrolyzed chicken extract. This seemingly unusual ingredient has been the focus of a study funded by Suntory Beverage & Food Asia, which has uncovered some interesting findings. The research, published in Frontiers in Nutrition, suggests that hydrolyzed chicken extract, known as ProBeptigen, may significantly improve perceived sleep quality in middle-aged adults with poor baseline sleep.
The study, conducted in Taiwan, involved 52 healthy subjects aged between 35 and 65 years old who had poor sleep quality as indicated by a Pittsburgh Sleep Quality Index (PSQI) score of greater than 5. Participants were randomly assigned to receive either 670mg of ProBeptigen or a placebo daily for four weeks. While no significant difference was found in the PSQI global scores between the two groups, the ProBeptigen group showed a notable improvement in the subjective sleep quality component score, which was statistically significant (p = 0.006).
This finding is particularly intriguing, as it aligns with previous research on protein hydrolysates. Studies have shown that bovine alpha-S1 casein tryptic hydrolysate and fish hydrolysate can improve sleep quality in Japanese and German populations, respectively. However, these studies did not find statistically significant differences between the supplement and placebo groups, which is why the current study's findings are so noteworthy.
The researchers suggest that the specific bioactive constituents in hydrolyzed chicken extract may contribute to a stronger improvement in perceived sleep quality. ProBeptigen contains various diketopiperazines produced through enzymatic and thermal treatments, and prior in vivo studies suggest that certain diketopiperazines may influence neurotransmitter systems such as GABAergic signaling or exhibit sedative effects. Additionally, ProBeptigen contains tryptophan, a biochemical precursor of serotonin and melatonin, which are involved in well-characterized sleep regulatory pathways.
However, the study also highlights the need for further research. The exact bioactives and mechanisms by which ProBeptigen affects sleep quality remain unclear, and more studies are needed to clarify these hypotheses and identify the biological processes through which ProBeptigen may influence sleep. The authors suggest that larger sample sizes, objective sleep measures, and alternative dosing schedules should be incorporated into future research.
In conclusion, this study provides an exciting glimpse into the potential of hydrolyzed chicken extract as a supportive nutritional supplement for managing sleep health. While more research is needed, the findings suggest that ProBeptigen could be a valuable addition to a multifaceted sleep management strategy, particularly for middle-aged adults struggling with sleep difficulties. As we continue to explore the complex world of sleep science, ingredients like ProBeptigen may offer a promising avenue for improving sleep quality and overall well-being.
